You're signed outSign in or to get full access.
About
Naveen Yalamanchi, MD is a Partner and Portfolio Manager at RTW Investments, LP, a leading healthcare-focused investment firm headquartered in New York. He serves on RTW's executive leadership team and directs the firm's medical technology investment strategy, overseeing portfolio selection and driving thought leadership for investments in cutting-edge healthcare sectors.
Dr. Yalamanchi specializes in medical devices, life sciences, diagnostics, and digital health, with a focus on emerging technologies that improve patient outcomes. His expertise lies in identifying, cultivating, and accelerating transformative opportunities within these asset classes, managing investments in innovative companies that are shaping the future of healthcare.
He brings over 20 years of investment and research experience, having previously held senior roles at Black Capital/Calamos Arista Partners, Millennium Management, and Davidson Kempner Capital Management. Dr. Yalamanchi graduated Phi Beta Kappa with a BS in Biology from MIT, earned his MD from Stanford University School of Medicine, and completed an orthopedic surgery internship at UCLA. He is recognized for his contributions to healthcare investing and serves on leadership councils at UC Irvine and the Orange County Sheriff's Advisory Council (effective 2025).
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| RTW Investments, LP | Partner | Jan 2015 to Present | — |
| UC Irvine Charlie Dunlop School of Biological Sciences | Dean's Leadership Council | Jan 2025 to Present | — |
| Orange County Sheriff's Advisory Council | Council Member | Mar 2025 to Present | — |
| Ancora Heart, Inc. | Board Observer | Jan 2019 to Present | — |
| Magnolia Medical Technologies | Board Observer | Dec 2018 to Present | — |
| Rocket Pharmaceuticals | Co-Founder and Board Director | Jan 2015 to Jan 2025 | A clinical stage gene therapy company. Lead indications include: Danon Disease, Fanconi Anemia, Pyruvate Kinase Deficiency. (NASDAQ: RCKT)
www.rocketpharma.com |
| Beta Bionics | Board Observer | Jan 2023 to Sep 2024 | — |
| Health Sciences Acquisition Corporation 2 | Chief Financial Officer | Jun 2020 to Jan 2023 | Health Sciences Acquisitions Corporation 2 (NASDAQ: HSAQ) completed a business combination with Orchestra Biomed (NASDAQ:OBIO) in Jan 2023. |
| Health Sciences Acquisitions Corporation | Chief Financial Officer | Jan 2019 to Dec 2019 | Health Sciences Acquisitions Corporation (NASDAQ: HSAC) merged with Immunovant Ltd on December 18, 2019. The combined entity is "Immunovant, Inc" (NASDAQ: IMVT). |
| DermTech | Board Observer | Sep 2017 to Aug 2019 | — |
| Calamos Arista | Healthcare Portfolio Manager | Sep 2011 to Dec 2014 | Managed the healthcare strategy for three funds (long/short mutual fund, market-neutral product, hedge fund) on the Calamos Arista platform -- subsidiary of Calamos Investments, a multi-billion asset ... |
| RTW Investments, LLC | Portfolio Manager | Jan 2010 to Sep 2011 | Healthcare investment firm
(former Davidson Kempner team) |
| Millennium Partners | Healthcare Analyst | Jan 2009 to Dec 2009 | Analyst at Millennium Partners. Covering healthcare, with special focus on medical devices, tools, diagnostics, services. |
| Davidson Kempner Capital Management | Healthcare Equities Analyst | Jan 2006 to Dec 2008 | Healthcare analyst covering therapeutics and non-therapeutics |
| UCLA Medical Center | Orthopedic Surgery Resident | Jan 2004 to Jan 2005 | Physician |
Education
Stanford University School of Medicine
1999 — 2004
Massachusetts Institute of Technology
1995 — 1999
Skills & Expertise
Others at RTW Investments, LP (14)
| Name | Role | Location |
|---|---|---|
 | Partner | New York, NY , United States |
 | Research Associate | Scarsdale, NY , United States |
 | Head Trader | New York, NY , United States |
R Robert Rapaport | Research Analyst | New York, NY , United States |
 | Senior Analyst | New York, NY , United States |
 | Research Analyst | NY , United States |
J Jeffrey Wang | Research Analyst | New York, NY , United States |
 | Partner | New York, NY , United States |
L Lauren Lee | Research Analyst | New York, NY , United States |
L Luc Ghaleb | Associate | New York, NY , United States |
Similar Fund Managers
| Name | Role | Fund | Location |
|---|---|---|---|
A Andrey Belov | Research Analyst | Cramer Rosenthal Mcglynn LLC | Stamford, CT , United States |
B Brian Harvey | Equity Portfolio Manager | Cramer Rosenthal Mcglynn LLC | United States |
